Browse Category

Health Care News 3 October 2025 - 29 October 2025

CVS Health Stock Rockets After Blockbuster Q3 Results, Raises Profit Outlook

CVS Health Stock Rockets After Blockbuster Q3 Results, Raises Profit Outlook

In Wednesday’s earnings announcement, CVS Health (NYSE: CVS) beat expectations across the board. The pharmacy-and-insurance giant reported Q3 total sales of $102.9 billion and adjusted profit of $1.60 per share cvshealth.com gurufocus.com, handily exceeding consensus. Revenue was about $7.5 billion higher than a year ago, driven by volume gains and modest price increases. The results “exceeded Wall Street’s expectations,” according to the Associated Press timesunion.com. Management simultaneously hiked its full-year guidance: adjusted earnings are now seen at $6.55–$6.65 per share cvshealth.com timesunion.com. This marks CVS’s third profit outlook raise in 2025, reflecting confidence in its turnaround plan. Investors rewarded the news –
UnitedHealth Group Stock Surges Amid Analyst Upgrades: Is Wall Street Turning Bullish on UNH in 2025?

UnitedHealth Stock Soars After Q3 Shock – Is a Bigger Rally Ahead?

UnitedHealth’s third-quarter report released Oct. 28 largely vindicated that turnaround strategy. Revenue climbed 12% year-over-year to $113.2 billion, helped by strong growth in both its insurance (UnitedHealthcare) and health-services (Optum) units businesswire.com. The company delivered adjusted EPS of $2.92, beating the $2.80 Wall Street average marketscreener.com, despite EPS plunging from $7.15 a year ago due to higher costs. On the call, Hemsley noted that results were on track with management’s plan: “We remain focused on strengthening performance and positioning for durable and accelerating growth in 2026 and beyond,” he said marketscreener.com. UnitedHealth also raised its full-year 2025 profit outlook to at least
28 October 2025
Humana (HUM) Stock Skyrockets on Medicare News – What Investors Must Know Today

Humana Stock Skyrockets as Medicare Advantage News Ignites Rally

Stock Performance and Recent Moves On Oct. 3, 2025 Humana’s stock surged sharply – closing up ~10.6% after a late afternoon rally stockstory.org. Intraday gains peaked around +11.9% as news broke that Humana’s Medicare Advantage star ratings and plan enhancements were better than feared. (By comparison, the prior day Humana had already jumped ~6% on Oct. 2 when preliminary MA star ratings were disclosed stockstotrade.com.) The Oct. 3 close near $283.72 was well above the ~$256 level of just days earlier, reflecting strong investor enthusiasm. Trading volume was heavy, and market commentary noted that moves of this size are rare
3 October 2025
Go toTop